JPS51123813A - Production of cephalosporin for nonnaural administration - Google Patents

Production of cephalosporin for nonnaural administration

Info

Publication number
JPS51123813A
JPS51123813A JP51036674A JP3667476A JPS51123813A JP S51123813 A JPS51123813 A JP S51123813A JP 51036674 A JP51036674 A JP 51036674A JP 3667476 A JP3667476 A JP 3667476A JP S51123813 A JPS51123813 A JP S51123813A
Authority
JP
Japan
Prior art keywords
nonnaural
cephalosporin
administration
production
nonnaural administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP51036674A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6143356B2 (enExample
Inventor
Deii Shiizu Maikeru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JPS51123813A publication Critical patent/JPS51123813A/ja
Publication of JPS6143356B2 publication Critical patent/JPS6143356B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP51036674A 1975-04-11 1976-04-01 Production of cephalosporin for nonnaural administration Granted JPS51123813A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/567,224 US4029655A (en) 1975-04-11 1975-04-11 Method of preparing stable sterile crystalline cephalosporins for parenteral administration

Publications (2)

Publication Number Publication Date
JPS51123813A true JPS51123813A (en) 1976-10-28
JPS6143356B2 JPS6143356B2 (enExample) 1986-09-26

Family

ID=24266257

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51036674A Granted JPS51123813A (en) 1975-04-11 1976-04-01 Production of cephalosporin for nonnaural administration

Country Status (11)

Country Link
US (2) US4029655A (enExample)
JP (1) JPS51123813A (enExample)
BE (1) BE840280A (enExample)
CA (1) CA1068680A (enExample)
DE (1) DE2614668C2 (enExample)
ES (1) ES446906A1 (enExample)
FR (1) FR2306993A1 (enExample)
GB (1) GB1537874A (enExample)
IE (1) IE42955B1 (enExample)
IL (1) IL49073A (enExample)
NL (1) NL7603659A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
JPS60178814A (ja) * 1984-02-22 1985-09-12 Shionogi & Co Ltd セフアロチンナトリウムの結晶性凍結乾燥製剤の製造法

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
IL53427A0 (en) * 1976-11-24 1978-01-31 Lilly Co Eli Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration
US4115644A (en) * 1977-09-19 1978-09-19 Eli Lilly And Company Process for preparing pure cefamandole from alkali metal and ammonium salts thereof
US4132848A (en) * 1977-11-03 1979-01-02 Eli Lilly And Company Method of preparing a rapidly dissolving powder of crystalline cephalothin sodium for parenteral administration
FR2421905A1 (fr) * 1977-11-24 1979-11-02 Lilly Co Eli Preparation d'une poudre de cephalothine-sodiu m stable, pour administration parenterale
JPS54147917A (en) * 1978-05-08 1979-11-19 Sumitomo Chem Co Ltd Ferrze-drying method
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US5244891A (en) * 1985-08-05 1993-09-14 Bristol-Myers Squibb Company Injectable compositions of cefepime dihydrochloride hydrate
US4714760A (en) * 1985-08-20 1987-12-22 Bristol-Myers Company Cephalosporin intermediates
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
TW264475B (enExample) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
US6111098A (en) * 1994-05-02 2000-08-29 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
DE602005002742T2 (de) * 2004-04-22 2008-01-24 Pfizer Products Inc., Groton Verfahren zur stabilisierung von ungeordnetem cefovecin-natriumsalz
CN101759708B (zh) * 2008-12-23 2012-07-04 深圳信立泰药业股份有限公司 头孢地嗪钠晶型及其制备方法和含有该晶型的药物组合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3085884A (en) * 1958-07-28 1963-04-16 Liquefreeze Company Inc Method of freezing and shipping foodstuffs
GB1234802A (en) * 1968-04-19 1971-06-09 British American Tobacco Co Improvements relating to the packing of liquids
US3725003A (en) * 1969-11-04 1973-04-03 Moore Perk Corp Method of sterile packaging

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120886A (ja) * 1983-12-02 1985-06-28 Takeda Chem Ind Ltd セフェムカルボン酸のナトリウム塩の結晶
JPS60178814A (ja) * 1984-02-22 1985-09-12 Shionogi & Co Ltd セフアロチンナトリウムの結晶性凍結乾燥製剤の製造法

Also Published As

Publication number Publication date
CA1068680A (en) 1979-12-25
IL49073A (en) 1979-03-12
BE840280A (fr) 1976-10-01
DE2614668C2 (de) 1986-10-30
DE2614668A1 (de) 1976-10-21
US4104391A (en) 1978-08-01
IL49073A0 (en) 1976-04-30
JPS6143356B2 (enExample) 1986-09-26
NL7603659A (nl) 1976-10-13
FR2306993B1 (enExample) 1978-11-17
GB1537874A (en) 1979-01-04
IE42955L (en) 1976-10-11
FR2306993A1 (fr) 1976-11-05
US4029655A (en) 1977-06-14
ES446906A1 (es) 1977-05-16
IE42955B1 (en) 1980-11-19

Similar Documents

Publication Publication Date Title
JPS51118763A (en) Production of alkylenecarbonate
JPS51123813A (en) Production of cephalosporin for nonnaural administration
JPS5236683A (en) Production of riphamycin
JPS5214793A (en) Production of cephalosporin compound
JPS5212162A (en) Production of phenylindoline
JPS51141897A (en) Production of riphamycin
JPS5251392A (en) Production of triazolopyridazinones
JPS51131873A (en) Production of 44loneralkyll 55cyanoooxazole
JPS5251389A (en) Production of cephalosporin intermediate
JPS5248684A (en) Production of ureidocephalosporin derivative
JPS5248698A (en) Production of riphamycin
JPS5265295A (en) Production of antibiotic
JPS5219695A (en) Production of tetrahydrothiopyranopyrazols
JPS5238090A (en) Production of 55androstenn 177one derivative
JPS5248689A (en) Production of pyrazolopyridineketones
JPS51115465A (en) Production of 55phenyll 22framidoxime
JPS5227758A (en) Production of 22methyll 11naphthol
JPS51125379A (en) Production of aminopyrole derivatives
JPS525790A (en) Production of penicillin
JPS5248662A (en) Production of 44hydroxymethyll 22pyrorysines
JPS51138668A (en) Production of 211hydroxyy 166pregnenn200one derivatives
JPS5236690A (en) Production of 33methoxymethlcephalosporin
JPS5212991A (en) Production of bioprotein
JPS5246100A (en) Production of pyrazolopyridopirimidine
JPS5253890A (en) Production of cephalosporin type compound